• 1
    Potter MN, Foot AB, Oakhill A. Influenza A and the virus associated haemophagocytic syndrome: cluster of three cases in children with acute leukaemia. J Clin Pathol1991; 44:297299.
  • 2
    Kempe A, Hall CB, MacDonald NE et al. Influenza in children with cancer. J Pediatr1989; 115:3339.
  • 3
    Feldman S, Webster RG, Sugg M. Influenza in children and young adults with cancer: 20 cases. Cancer1977; 39:350353.
  • 4
    Kersun LS, Coffin SE, Leckerman KH, Ingram M, Reilly AF. Community acquired influenza requiring hospitalization: vaccine status is unrelated to morbidity in children with cancer. Pediatr Blood Cancer2010; 54:7982.
  • 5
    Tasian SK, Park JR, Martin ET, Englund JA. Influenza-associated morbidity in children with cancer. Pediatr Blood Cancer2008; 50:983987.
  • 6
    Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med2003; 348:867868.
  • 7
    Klimov AI, Rocha E, Hayden FG, Shult PA, Roumillat LF, Cox NJ. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis1995; 172:13521355.
  • 8
    Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep2006; 55:148.
  • 9
    General recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. Centers for Disease Control. 2011; 60:164.
  • 10
    Crawford NW, Heath JA, Buttery JP. Immunisation practices of paediatric oncologists: an Australasian survey. J Paediatr Child Health2007; 43:593596.
  • 11
    Porter CC, Poehling KA, Hamilton R, Frangoul H, Cooper WO. Influenza immunization practices among pediatric oncologists. J Pediatr Hematol Oncol2003; 25:134138.
  • 12
    Goossen GM, Kremer LC, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev2009; 2:CD006484.
  • 13
    Esposito S, Cecinati V, Scicchitano B et al. Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy. Vaccine2010; 28:15581565.
  • 14
    Reilly A, Kersun LS, McDonald K, Weinberg A, Jawad AF, Sullivan KE. The efficacy of influenza vaccination in a pediatric oncology population. J Pediatr Hematol Oncol2010; 32:e177e181.
  • 15
    Monkman K, Mahony J, Lazo-Langner A, Chin-Yee BH, Minuk LA. The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies. Leuk Lymphoma2011; 52:17361741.
  • 16
    Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer2005; 45:831837.
  • 17
    Hsieh YC, Lu MY, Kao CL et al. Response to influenza vaccine in children with leukemia undergoing chemotherapy. J Formos Med Assoc (Taiwan) 2002; 101:700704.
  • 18
    Porter CC, Edwards KM, Zhu Y, Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer2004; 42:3640.
  • 19
    Carr S, Allison KJ, Van De Velde LA et al. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis2011; 204:14751482.
  • 20
    Yen TY, Jou ST, Yang YL et al. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer. Pediatr Blood Cancer2011; 57:11541158.
  • 21
    Bate J, Yung CF, Hoschler K et al. Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. Clin Infect Dis: an official publication of the Infectious Diseases Society of America 2010; 51:e95e104.
  • 22
    Shahgholi E, Ehsani MA, Salamati P, Maysamie A, Sotoudeh K, Mokhtariazad T. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy. Pediatr Blood Cancer2010; 54:716720.
  • 23
    Chisholm JC, Devine T, Charlett A, Pinkerton CR, Zambon M. Response to influenza immunisation during treatment for cancer. Arch Dis Child2001; 84:496500.
  • 24
    Chisholm J, Howe K, Taj M, Zambon M. Influenza immunisation in children with solid tumours. Eur J Cancer2005; 41:22802287.
  • 25
    Gross PA, Lee H, Wolff JA, Hall CB, Minnefore AB, Lazicki ME. Influenza immunization in immunosuppressed children. J pediatr1978; 92:3035.
  • 26
    Steinherz PG, Brown AE, Gross PA et al. Influenza immunization of children with neoplastic diseases. Cancer1980; 45:750756.
  • 27
    Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2011-2012. Pediatrics2011; 128:813825.
  • 28
    Levin MJ, Song LY, Fenton T et al. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine2008; 26:42104217.
  • 29
    Sutter JA, Kwan-Morley J, Dunham J et al. A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery. Clin Immunol2008; 126:282290.
  • 30
    Stadtmauer EA, Vogl DT, Luning Prak E et al. Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial. Blood2011; 117:6371.
  • 31
    Jawad AF, Prak EL, Boyer J et al. A Prospective Study of Influenza Vaccination and a Comparison of Immunologic Parameters in Children and Adults with Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome). J Clin Immunol2011; 31:927935.
  • 32
    Chik KW, Li CK, Chan PK et al. Oseltamivir prophylaxis during the influenza season in a paediatric cancer centre: prospective observational study. Hong Kong Med J2004; 10:103106.
  • 33
    Vu D, Peck AJ, Nichols WG et al. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. Clin Infect Dis: an official publication of the Infectious Diseases Society of America 2007; 45:187193.
  • 34
    Caver TE, Slobod KS, Flynn PM et al. Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 1998; 12:619622.
  • 35
    Goossen GM, Kremer LC, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev2009; 15:CD006484.
  • 36
    Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis2012; 12:3644.
  • 37
    Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev2008; 16:CD004879.